Israel Englander’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
NCNMGF
FCM
SAM
KCM
MBAM
Israel Englander's XGN Position: Q2 2026 in Review
Israel Englander sold out of Exagen (XGN) in Q2 2026, closing a stake of 56,069 shares — an estimated $168K sold.
Israel Englander first reported a position in XGN in Q3 2019 and held it in 18 quarters. The position peaked at $2.72M in Q3 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.
- Israel Englander reported no remaining Exagen position as of Q2 2026 after selling out during the quarter.
- Israel Englander sold 56,069 Exagen shares in Q2 2026, an estimated $168K.
- Israel Englander first reported a position in Exagen in Q3 2019 and held it in 18 quarters.
- Israel Englander's Exagen position peaked at $2.72M in Q3 2025.
- 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.